 <h1>Ipratropium Inhalation Solution Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>ipratropium</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about ipratropium. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Ipratropium Inhalation Solution.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to ipratropium: inhalation solution</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, ipratropium (the active ingredient contained in Ipratropium Inhalation Solution) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking ipratropium:</p><p>
<i>More common</i>
</p><ul>
<li>Bladder pain</li>
<li>bloody or cloudy urine</li>
<li>cough producing mucus</li>
<li>difficult, burning, or painful urination</li>
<li>difficulty with breathing</li>
<li>frequent urge to urinate</li>
<li>lower back or side pain</li>
<li>shortness of breath</li>
<li>tightness in the chest</li>
<li>wheezing</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Body aches or pain</li>
<li>chills</li>
<li>cough</li>
<li>ear congestion</li>
<li>fever</li>
<li>headache</li>
<li>loss of voice</li>
<li>runny nose</li>
<li>sneezing</li>
<li>sore throat</li>
<li>unusual tiredness or weakness</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Constipation (continuing) or lower abdominal pain or bloating</li>
<li>fainting</li>
<li>fast, pounding, or irregular heartbeat or pulse</li>
<li>severe eye pain</li>
<li>skin rash or hives</li>
<li>swelling of the face, lips, or eyelids</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Blindness</li>
<li>blurred vision</li>
<li>confusion</li>
<li>decrease in the frequency of urination</li>
<li>decrease in the urine volume</li>
<li>decreased vision</li>
<li>difficulty in passing urine (dribbling)</li>
<li>difficulty with swallowing</li>
<li>dizziness</li>
<li>dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position</li>
<li>hives or welts</li>
<li>itching</li>
<li>large, hive-like swelling on the face, eyelids, lips, tongue, throat, hands, legs, feet, or sex organs</li>
<li>nausea or vomiting</li>
<li>noisy breathing</li>
<li>puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue</li>
<li>redness of the skin</li>
<li>redness of the white part of the eyes or inside of the eyelids</li>
<li>sweating</li>
<li>tearing</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of ipratropium may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Back pain</li>
<li>dryness of the mouth</li>
<li>unpleasant taste</li>
</ul><p>
<i>Less common or rare</i>
</p><ul>
<li>Acid or sour stomach</li>
<li>belching</li>
<li>burning eyes</li>
<li>diarrhea</li>
<li>general feeling of discomfort or illness</li>
<li>heartburn</li>
<li>indigestion</li>
<li>joint pain</li>
<li>loss of appetite</li>
<li>muscle aches and pains</li>
<li>nervousness</li>
<li>pain or tenderness around the eyes and cheekbones</li>
<li>shivering</li>
<li>stomach discomfort, upset, or pain</li>
<li>trembling</li>
<li>trouble sleeping</li>
</ul><p>
<!-- end inhalation solution --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to ipratropium: compounding powder, inhalation aerosol, inhalation solution</i></p><h3>General</h3><p>The most common adverse reactions were bronchitis, COPD exacerbation, dyspnea, headache, throat irritation, cough, dry mouth, gastro-intestinal motility disorders (including constipation, diarrhea and vomiting), nausea, and dizziness.<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Very common</b> (10% or more): Bronchitis (up to 14.6%), upper respiratory tract infection (up to 13.2%)</p>
<p><b>Common</b> (1% to 10%): Chest pain, cough, dyspnea, bronchospasm, sputum increased, pharyngitis, rhinitis, sinusitis, throat irritation</p>
<p><b>Uncommon</b> (0.1% to 1%): Paradoxical bronchospasm, laryngospasm, pharyngeal edema, dry throat<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Mouth dryness, nausea, gastrointestinal motility disorder, dyspepsia</p>
<p><b>Uncommon</b> (0.1% to 1%): Constipation, diarrhea, taste perversion, vomiting, stomatitis</p>
<p><b>Frequency not reported</b>: Mouth edema<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Urinary tract infection</p>
<p><b>Uncommon</b> (0.1% to 1%): Urinary retention<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Back pain</p>
<p><b>Uncommon</b> (0.1% to 1%): Arthritis<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Headache, dizziness</p>
<p><b>Uncommon</b> (0.1% to 1%): Tremor, nervousness<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Influenza-like symptoms, pain<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Uncommon</b> (0.1% to 1%): Hypertension, palpitations, supraventricular tachycardia</p>
<p><b>Rare</b> (less than 0.1%): Atrial fibrillation, rate increased</p>
<p><b>Frequency not reported</b>: Hypotension, palpitation, tachycardia<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Uncommon</b> (0.1% to 1%): Rash, pruritus</p>
<p><b>Rare</b> (less than 0.1%): Urticaria<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Uncommon</b> (0.1% to 1%): Hypersensitivity, anaphylactic reactions, angioedema of tongue, lips, face</p>
<p><b>Frequency not reported</b>: Urticaria (including giant urticaria), laryngospasm<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Uncommon</b> (0.1% to 1%): Blurred vision, mydriasis, intraocular pressure increased, glaucoma, eye pain, halo vision, conjunctival hyperemia, corneal edema</p>
<p><b>Rare</b> (less than 0.1%): Accommodation disorder</p>
<p><b>Frequency not reported</b>: Precipitation or worsening of narrow-angle glaucoma, acute eye pain<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. "Ipratropium." Med Lett Drugs Ther 29 (1987): 71-2</p><p id="ref_2">2. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_3">3. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_4">4. Pakes GE, Brogden RN, Heel RC, Speight TM, Avery GS "Ipratropium bromide: a review of its pharmacological properties and therapeutic efficacy in asthma and chronic bronchitis." Drugs 20 (1980): 237-66</p><p id="ref_5">5. Anderson WM "Hemodynamic and non-bronchial effects of ipratropium bromide." Am J Med 81 (1986): 45-53</p><p id="ref_6">6. Gross NJ "Ipratropium bromide." N Engl J Med 319 (1988): 486-94</p><p id="ref_7">7. "Product Information. Atrovert (ipratropium)." Boehringer-Ingelheim, Ridgefield, CT. </p><p id="ref_8">8. "Product Information. Atrovent (ipratropium)." Boehringer-Ingelheim, Ridgefield, CT. </p><p id="ref_9">9. Massey KL, Gotz VP "Ipratropium bromide." Drug Intell Clin Pharm 19 (1985): 5-12</p><p id="ref_10">10. Levin DC, Little KS, Laughlin KR, Galbraith JM, Gustman PM, Murphy D, Kram JA, Hardie G, Reuter C, Ostransky D, Mcfarland K "Addition of anticholinergic solution prolongs bronchodilator effect of beta(2) agonists in patients with chronic obstructive pulmonary disease." Am J Med 100 Suppl (1996): s40-8</p><p id="ref_11">11. Pras E, Stienlauf S, Pinkhas J, Sidi Y "Urinary retention associated with ipratropium bromide." DICP 25 (1991): 939-40</p><p id="ref_12">12. Verheijen-Breemhaar L, Bogaard JM, Hilvering C "Comparison of the bronchodilatory action and side-effects of ipratropium bromide and thiazinamium methyl sulphate: a long-term, double-blind, crossover trial in patients with chronic bronchitis." Pharmatherapeutica 3 (1982): 180-7</p><p id="ref_13">13. Lozewicz S "Bladder outflow obstruction induced by ipratropium bromide." Postgrad Med J 65 (1989): 260-1</p><p id="ref_14">14. Braun SR, Levy SF "Comparison of ipratropium bromide and albuterol in chronic obstructive pulmonary disease: a three-center study." Am J Med 91 (1991): s28-32</p><p id="ref_15">15. O'Driscoll BR "Supraventricular tachycardia caused by nebulised ipratropium bromide." Thorax 44 (1989): 312</p><p id="ref_16">16. Cabana MD, Johnson H, Lee CKK, Helfaer M "Transient anisocoria secondary to nebulized ipratropium bromide." Clin Pediat 37 (1998): 445-7</p><p id="ref_17">17. Kizer KM, Bess DT, Bedford NK "Blurred vision from ipratropium bromide." Am J Health Syst Pharm 56 (1999): 914</p></div>
<div class="more-resources" id="moreResources">
<h2>More about Ipratropium Inhalation Solution (ipratropium)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>1 Review</li>
<li>Drug class: anticholinergic bronchodilators</li>
</ul>
<h3>Consumer resources</h3>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Atrovent, Atrovent HFA</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Asthma</li>
<li>COPD, Maintenance</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to ipratropium: compounding powder, inhalation aerosol, inhalation solution</i></p><h3>General</h3><p>The most common adverse reactions were bronchitis, COPD exacerbation, dyspnea, headache, throat irritation, cough, dry mouth, gastro-intestinal motility disorders (including constipation, diarrhea and vomiting), nausea, and dizziness.<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Very common</b> (10% or more): Bronchitis (up to 14.6%), upper respiratory tract infection (up to 13.2%)</p><p><b>Common</b> (1% to 10%): Chest pain, cough, dyspnea, bronchospasm, sputum increased, pharyngitis, rhinitis, sinusitis, throat irritation</p><p><b>Uncommon</b> (0.1% to 1%): Paradoxical bronchospasm, laryngospasm, pharyngeal edema, dry throat<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Mouth dryness, nausea, gastrointestinal motility disorder, dyspepsia</p><p><b>Uncommon</b> (0.1% to 1%): Constipation, diarrhea, taste perversion, vomiting, stomatitis</p><p><b>Frequency not reported</b>: Mouth edema<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Urinary tract infection</p><p><b>Uncommon</b> (0.1% to 1%): Urinary retention<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Back pain</p><p><b>Uncommon</b> (0.1% to 1%): Arthritis<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Headache, dizziness</p><p><b>Uncommon</b> (0.1% to 1%): Tremor, nervousness<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Influenza-like symptoms, pain<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Uncommon</b> (0.1% to 1%): Hypertension, palpitations, supraventricular tachycardia</p><p><b>Rare</b> (less than 0.1%): Atrial fibrillation, rate increased</p><p><b>Frequency not reported</b>: Hypotension, palpitation, tachycardia<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Uncommon</b> (0.1% to 1%): Rash, pruritus</p><p><b>Rare</b> (less than 0.1%): Urticaria<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Uncommon</b> (0.1% to 1%): Hypersensitivity, anaphylactic reactions, angioedema of tongue, lips, face</p><p><b>Frequency not reported</b>: Urticaria (including giant urticaria), laryngospasm<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Uncommon</b> (0.1% to 1%): Blurred vision, mydriasis, intraocular pressure increased, glaucoma, eye pain, halo vision, conjunctival hyperemia, corneal edema</p><p><b>Rare</b> (less than 0.1%): Accommodation disorder</p><p><b>Frequency not reported</b>: Precipitation or worsening of narrow-angle glaucoma, acute eye pain<sup>[Ref]</sup></p><p id="ref_1">1. "Ipratropium." Med Lett Drugs Ther 29 (1987): 71-2</p><p id="ref_2">2. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_3">3. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_4">4. Pakes GE, Brogden RN, Heel RC, Speight TM, Avery GS "Ipratropium bromide: a review of its pharmacological properties and therapeutic efficacy in asthma and chronic bronchitis." Drugs 20 (1980): 237-66</p><p id="ref_5">5. Anderson WM "Hemodynamic and non-bronchial effects of ipratropium bromide." Am J Med 81 (1986): 45-53</p><p id="ref_6">6. Gross NJ "Ipratropium bromide." N Engl J Med 319 (1988): 486-94</p><p id="ref_7">7. "Product Information. Atrovert (ipratropium)." Boehringer-Ingelheim, Ridgefield, CT. </p><p id="ref_8">8. "Product Information. Atrovent (ipratropium)." Boehringer-Ingelheim, Ridgefield, CT. </p><p id="ref_9">9. Massey KL, Gotz VP "Ipratropium bromide." Drug Intell Clin Pharm 19 (1985): 5-12</p><p id="ref_10">10. Levin DC, Little KS, Laughlin KR, Galbraith JM, Gustman PM, Murphy D, Kram JA, Hardie G, Reuter C, Ostransky D, Mcfarland K "Addition of anticholinergic solution prolongs bronchodilator effect of beta(2) agonists in patients with chronic obstructive pulmonary disease." Am J Med 100 Suppl (1996): s40-8</p><p id="ref_11">11. Pras E, Stienlauf S, Pinkhas J, Sidi Y "Urinary retention associated with ipratropium bromide." DICP 25 (1991): 939-40</p><p id="ref_12">12. Verheijen-Breemhaar L, Bogaard JM, Hilvering C "Comparison of the bronchodilatory action and side-effects of ipratropium bromide and thiazinamium methyl sulphate: a long-term, double-blind, crossover trial in patients with chronic bronchitis." Pharmatherapeutica 3 (1982): 180-7</p><p id="ref_13">13. Lozewicz S "Bladder outflow obstruction induced by ipratropium bromide." Postgrad Med J 65 (1989): 260-1</p><p id="ref_14">14. Braun SR, Levy SF "Comparison of ipratropium bromide and albuterol in chronic obstructive pulmonary disease: a three-center study." Am J Med 91 (1991): s28-32</p><p id="ref_15">15. O'Driscoll BR "Supraventricular tachycardia caused by nebulised ipratropium bromide." Thorax 44 (1989): 312</p><p id="ref_16">16. Cabana MD, Johnson H, Lee CKK, Helfaer M "Transient anisocoria secondary to nebulized ipratropium bromide." Clin Pediat 37 (1998): 445-7</p><p id="ref_17">17. Kizer KM, Bess DT, Bedford NK "Blurred vision from ipratropium bromide." Am J Health Syst Pharm 56 (1999): 914</p><h2>More about Ipratropium Inhalation Solution (ipratropium)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>1 Review</li>
<li>Drug class: anticholinergic bronchodilators</li>
</ul><h3>Consumer resources</h3><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Asthma</li>
<li>COPD, Maintenance</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>